Horacek J, Dockery C, Kopecek M, Spaniel F, Novak T, Tislerova B, Klirova M, Palenicek T, Höschl C.
Controlled Clinical Trial 2006; 27(5): 587-594 PubMed PMID: 17159818 Keywords: Adolescent, Adult, Basal Metabolism, Brain:metabolism, Brain Mapping, Female, Fluorodeoxyglucose F18:metabolism, Frontal Lobe:metabolism, Humans, Male, Middle Aged, Positron-Emission Tomography:methods, Psychomotor Performance, Schizophrenia:metabolism, T. CitationOBJECTIVES: With the aim to indicate the functional anatomical substrate of cognitive dysfunction in schizophrenia we evaluated the relati.....
Horacek J, Dockery C, Kopecek M, Spaniel F, Novak T, Tislerova B, Klirova M, Palenicek T, Höschl C. Regional brain metabolism as the predictor of performance on the Trail Making Test in schizophrenia. A 18FDG PET covariation study. Neuro Endocrinol Lett. 2006 Oct; 27(5): 587-594
Prasko J, Dockery C, Horácek J, Houbová P, Kosová J, Klaschka J, Pasková B, Praskova H, Seifertová D, Záleský R, Höschl C.
Journal Article 2006; 27(4): 473-481 PubMed PMID: 16891998 Keywords: Adolescent, Adult, Anxiety:drug therapy, Cognitive Therapy, Combined Modality Therapy, Female, Follow-Up Studies, Humans, Male, Middle Aged, Moclobemide:therapeutic use, Monoamine Oxidase Inhibitors:therapeutic use, Patient Dropouts, Phobic Disorders:drug. Citation: The aim of the study was to assess the 6-months treatment efficacy and 24-month follow up of three different therapeutic programs (A. mo.....
Prasko J, Dockery C, Horácek J, Houbová P, Kosová J, Klaschka J, Pasková B, Praskova H, Seifertová D, Záleský R, Höschl C. Moclobemide and cognitive behavioral therapy in the treatment of social phobia. A six-month controlled study and 24 months follow up. Neuro Endocrinol Lett. 2006 Aug; 27(4): 473-481
Prasko J, Pasková B, Záleský R, Novák T, Kopecek M, Bares M, Horácek J.
Journal Article 2006; 27(3): 327-332 PubMed PMID: 16816829 Keywords: Adult, Antidepressive Agents, Second-Generation:therapeutic use, Combined Modality Therapy, Double-Blind Method, Drug Resistance, Electric Stimulation Therapy:methods, Female, Humans, Male, Neuropsychological Tests, Obsessive-Compulsive Disorder:therapy, . CitationBACKGROUND: The goal of our study is to assess whether transcranial magnetic stimulation (rTMS) would facilitate the effect of antidepress.....
Prasko J, Pasková B, Záleský R, Novák T, Kopecek M, Bares M, Horácek J. The effect of repetitive transcranial magnetic stimulation (rTMS) on symptoms in obsessive compulsive disorder. A randomized, double blind, sham controlled study. Neuro Endocrinol Lett. 2006 Jun; 27(3): 327-332
Novák T, Horácek J, Mohr P, Kopecek M, Skrdlantová L, Klirova M, Rodriguez M, Spaniel F, Dockery C, Höschl C.
Journal Article 2006; 27(1-2): 209-213 PubMed PMID: 16648775 Keywords: Adult, Double-Blind Method, Female, Humans, Male, Neuropsychological Tests, Psychiatric Status Rating Scales, Schizophrenia:therapy, Schizophrenic Psychology, Transcranial Magnetic Stimulation,. Citation: The high-frequency repetitive transcranial magnetic stimulation (HF-rTMS) over the prefrontal cortex is a promising method for the treat.....
Novák T, Horácek J, Mohr P, Kopecek M, Skrdlantová L, Klirova M, Rodriguez M, Spaniel F, Dockery C, Höschl C. The double-blind sham-controlled study of high-frequency rTMS (20 Hz) for negative symptoms in schizophrenia: negative results. Neuro Endocrinol Lett. 2006 Apr; 27(1-2): 209-213
Kopecek M, Bares M, Horácek J.
Letter 2005; 26(4): 327-335 PubMed PMID: 16136015 Keywords: Adult, Antipsychotic Agents:adverse effects, Depressive Disorder:drug therapy, Female, Humans, Hyperprolactinemia:blood, Male, Middle Aged, Prolactin:blood, Sulpiride:adverse effects,. Citation.....
Kopecek M, Bares M, Horácek J. Normalization of hyperprolactinaemia after withdrawal of a low dose of amisulpride. Neuro Endocrinol Lett. 2005 Aug; 26(4): 327-335
Kopecek M, Bares M, Svarc J, Dockery C, Horácek J.
Clinical Trial 2004; 25(6): 419-422 PubMed PMID: 15665803 Keywords: Adult, Anti-Anxiety Agents:administration & dosage, Antidepressive Agents:administration & dosage, Antipsychotic Agents:administration & dosage, Depression:drug therapy, Drug Therapy, Combination, Female, Humans, Hyperprolactinemia:blood, Male, Middle Age. CitationOBJECTIVES: Amisulpride in antipsychotic doses can induce hyperprolactinemia. The aim of this study was to prove whether the same is true .....
Kopecek M, Bares M, Svarc J, Dockery C, Horácek J. Hyperprolactinemia after low dose of amisulpride. Neuro Endocrinol Lett. 2004 Dec; 25(6): 419-422